Cyclerion's sGC stimulator praliciguat ameliorates NASH in rodents

DISEASE CATEGORY: Hepatic

INDICATION: Non-alcoholic steatohepatitis (NASH)

Rat and mouse studies suggest the systemic sGC stimulator praliciguat could help treat NASH. In liver samples

Read the full 232 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE